Churchill Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Churchill Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-8,676	Closed	-$680K	–	169
2015 Q2	$680K	Sell	8,676 -1,035	-11%	-$80.6K	0.02%	150
2015 Q1	$742K	Sell	9,711 -3,439	-26%	-$253K	0.03%	149
2014 Q4	$875K	Sell	13,150 -1,991	-13%	-$133K	0.03%	139
2014 Q3	$964K	Sell	15,141 -2,380	-14%	-$147K	0.04%	148
2014 Q2	$1.07M	Sell	17,521 -85,274	-83%	-$4.94M	0.05%	135
2014 Q1	$5.82M	Sell	102,795 -3,010	-3%	-$171K	0.23%	34
2013 Q4	$5.66M	Buy	105,805 +16,282	+18%	+$815K	0.22%	28
2013 Q3	$4.12M	Sell	89,523 -7,712	-8%	-$352K	0.21%	31
2013 Q2	$4.11M	Buy	+97,235	New	+$4.05M	0.19%	29

Other funds holding PJP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

FIG

FundX Investment Group San Francisco, California $411M AUM 22.05% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Churchill Management's PJP Position: Q3 2015 in Review

Churchill Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2015, closing a stake of 8,676 shares — an estimated $680K sold.

Churchill Management first reported a position in PJP in Q2 2013 and held it in 9 quarters. The position peaked at $5.82M in Q1 2014. 106 funds tracked by Wall St. Rank hold PJP as of Q3 2015.

Churchill Management reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
Churchill Management sold 8,676 Invesco Pharmaceuticals ETF shares in Q3 2015, an estimated $680K.
Churchill Management first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 9 quarters.
Churchill Management's Invesco Pharmaceuticals ETF position peaked at $5.82M in Q1 2014.
106 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2015.

Based on Churchill Management's 13F filing for Q3 2015, filed 15 Oct 2015.